Innovation in ALS Trial Design & Clinical Outcome Measures

Time: 12:00 pm
day: Day One


  • Inclusion criteria can be used to ensure a homogenious trial population with regard to disease progression rate and other attributes
  • Well-designed open label follow on periods can support findings from placebocontrolled treatment
  • New outcome measures can enhance trial sensitivity and reduce participant burden